Maximus (MMS) Projected to Post Earnings on Thursday

Maximus (NYSE:MMS) is expected to release its Q4 2025 results before the market opens on Thursday, November 20th. Analysts expect the company to announce earnings of $1.63 per share and revenue of $1.3411 billion for the quarter. Individuals can check the company’s upcoming Q4 2025 earningsummary page for the latest details on the call scheduled for Thursday, November 20, 2025 at 9:00 AM ET.

Maximus Price Performance

NYSE MMS opened at $80.54 on Thursday. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The firm has a market capitalization of $4.54 billion, a price-to-earnings ratio of 14.83 and a beta of 0.57. The company has a 50 day simple moving average of $87.00 and a 200-day simple moving average of $78.91. Maximus has a 52-week low of $63.77 and a 52-week high of $92.50.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be given a $0.30 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.5%. Maximus’s dividend payout ratio is presently 22.10%.

Insider Transactions at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of the stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares in the company, valued at approximately $1,227,336.88. This represents a 10.65% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Maximus

A number of large investors have recently modified their holdings of the stock. Qube Research & Technologies Ltd raised its stake in shares of Maximus by 115.8% during the second quarter. Qube Research & Technologies Ltd now owns 379,342 shares of the health services provider’s stock worth $26,630,000 after buying an additional 203,521 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in Maximus during the 2nd quarter worth approximately $11,547,000. Jane Street Group LLC grew its holdings in Maximus by 941.2% during the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares during the period. BNP Paribas Financial Markets grew its holdings in Maximus by 197.1% during the second quarter. BNP Paribas Financial Markets now owns 43,945 shares of the health services provider’s stock valued at $3,085,000 after purchasing an additional 29,152 shares during the period. Finally, Bank of America Corp DE raised its holdings in Maximus by 5.4% in the second quarter. Bank of America Corp DE now owns 363,923 shares of the health services provider’s stock worth $25,547,000 after purchasing an additional 18,502 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MMS has been the topic of several research analyst reports. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 8th. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 27th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.00.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.